John Wilkin
Stock Analyst at Craig-Hallum
(2.92)
# 1,669
Out of 5,005 analysts
5
Total ratings
80%
Success rate
27.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Initiates: Buy | $12 | $10.96 | +9.49% | 1 | Jul 23, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $14.38 | +4.31% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $36.00 | +25.00% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $7.34 | +8.99% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $8.06 | +259.80% | 1 | Feb 12, 2025 |
Exagen
Jul 23, 2025
Initiates: Buy
Price Target: $12
Current: $10.96
Upside: +9.49%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $14.38
Upside: +4.31%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $36.00
Upside: +25.00%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $7.34
Upside: +8.99%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $8.06
Upside: +259.80%